Chemistry:Oxelumab
From HandWiki
Oxelumab is a human monoclonal antibody targeting OX40L designed for the treatment of asthma.[1][2]
Oxelumab was developed by Genentech and co-developed by Roche.
References
- ↑ "Statement On A Nonproprietary Name Adopted By The USAN Council: Oxelumab". American Medical Association. http://www.ama-assn.org/resources/doc/usan/oxelumab.pdf.
- ↑ "B-Cell Inhibitors in Phase 1 and 2 Clinical Studies for Immunological Disorders". Handbook of Therapeutic Antibodies. 2014. pp. 1079–1114 (1093). doi:10.1002/9783527682423.ch33. ISBN 978-3-527-32937-3.
 |  |
